Minutes from Extraordinary General Meeting

17 Sep 2024 11:00 CEST

The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid
meeting on 17 September 2024.

All proposals on the agenda were adopted, cf. the notification of the
Extraordinary General Meeting that was published on Oslo Stock Exchange on 3
September 2024. The complete minutes of the Extraordinary General Meeting are
attached and will be available on https://lifecare.no/investor-relations/

About us
Lifecare ASA is a clinical stage medical sensor company developing technology
for sensing and monitoring of various body analytes. Lifecare's main focus is
to bring the next generation of Continuous Glucose Monitoring ("CGM") systems
to market. Lifecare enables osmotic pressure as sensing principle, combined
with the ability to manipulate Nano-granular Tunnelling Resistive sensors
("NTR") on the sensor body for read-out of pressure variations. Lifecare's
sensor technology is referred to as "Sencell" and is suitable for identifying
and monitoring the occurrence of a wide range of analytes and molecules in the
human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

This information is subject to disclosure under the Norwegian Securities
Trading Act, §5-12. The information was submitted for publication at
2024-09-17 11:00 CEST.

More information:
Access the news on Oslo Bors NewsWeb site

627949_2024 09 17 Extraordinary General Meeting Minutes V1.pdf
627949_Minutes from Extraordinary General Meeting.pdf